T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking
A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 188 participants.
Also called NCT07422831
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 188 participants
- Registry
-
NCT07422831
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT07422831. Randomized; no masking; primary purpose treatment. Start 2026-04-02 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking
- Acronym
- T2D INSIGHT
- Condition
- Type 2 Diabetes
- Condition
- Non Insulin Dependent Diabetes
- Intervention (Device)
- Periodic, over-the-counter continuous glucose monitoring
- Lead sponsor
- University of Colorado, Denver
- Collaborator
- American Diabetes Association
Record details
- Record id
cardio:ct-nct07422831- Content hash
14ab483f064b1dad1c964fdf8b4edfbeecd03748575c0b21a88baeb1813da27b